Company / Revenue
Eton Pharmaceuticals, Inc. Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$31.6M
FY2025
5-year range
$39.0K / $31.6M
FY2021-FY2025
Trend
+48.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 7 years, ranging from $39,000 in FY2022 to $32M in FY2025.
Based on SEC 10-K filings.
$32M in FY2025 with a 5-year CAGR of +101.2%.
Improved from $22M to $32M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +832.7%
- 5-Year CAGR
- +101.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +101.2%, indicating consistent growth.
- In FY2025, revenue increased 48.9% year-over-year.
- Lowest revenue in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $31.6M | +48.9% |
| FY2024 | $21.3M | -2.7% |
| FY2023 | $21.8M | +55879.5% |
| FY2022 | $39.0K | -95.9% |
| FY2021 | $959.0K | +0.0% |
| FY2020 | $959.0K | +91.8% |
| FY2019 | $500.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026